Content about Diabetes

April 2, 2012
Metformin may help slow progression, reduce risk of certain cancers

A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

NEW YORK — A medication commonly prescribed for patients with Type 2 diabetes also may play a critical role in patients at risk of developing certain cancers.

In three separate studies published in Cancer Prevention Research, a journal of the American Association for Cancer Research, findings showed how metformin may protect against oral cancer and liver cancer, as well as slow the growth rate of prostate cancer among men prior to prostatectomy.

March 30, 2012
Daiichi Sankyo, NGM to develop diabetes drugs

Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

SOUTH SAN FRANCISCO, Calif. — Daiichi Sankyo and NGM Biopharmaceuticals said they signed a research and licensing agreement to develop treatments for Type 1 and Type 2 diabetes. The drugs would work by reviving beta cells, the decline of which contributes to the disease.

March 29, 2012
American Diabetes Association debuts new diabetes risk test

In line with the 24th annual American Diabetes Association Alert Day, the American Diabetes Association debuted its new and improved diabetes risk test.

ALEXANDRIA, Va. — In line with the 24th annual American Diabetes Association Alert Day, the American Diabetes Association debuted its new and improved diabetes risk test.

March 29, 2012
Study suggests metformin may help prevent heart disease

A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

NEW YORK — A commonly prescribed diabetes drug also may have the capability of protecting the heart, according to a Swedish study.

March 28, 2012
Walgreens, National Urban League partner on Way to Well Health Tour

Walgreens and the National Urban League on Wednesday launched the Walgreens Way to Well Health Tour with National Urban League as a charitable component of the Walgreens Way to Well Commitment.

DEERFIELD, Ill. — Walgreens and the National Urban League on Wednesday launched the Walgreens Way to Well Health Tour with National Urban League as a charitable component of the Walgreens Way to Well Commitment. The national tour provides free health resources to residents in urban and minority communities who experience disproportionately higher rates of preventable diseases, the companies stated. The service is free and insurance will not be billed.

March 26, 2012
Report: Metformin cost-effective strategy in battling diabetes

Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

ALEXANDRIA, Va. — Lifestyle intervention and treatment with metformin provide safe, long-term, cost-effective means of preventing Type 2 diabetes and should be incorporated into prevention strategies for reducing the dramatic rise in incidence of Type 2 diabetes in the United States, according to two new analyses and an editorial published in the April issue of Diabetes Care.

March 26, 2012
Walgreens, Duane Reade to square off on ADA fundraising competition

Walgreens and Duane Reade stores are facing off on a challenge regarding which banner can raise the most funds over a four-week period in the fall in support of the American Diabetes Association Greater New York City Area, the ADA announced Monday.

NEW YORK — Walgreens and Duane Reade stores are facing off on a challenge regarding which banner can raise the most funds over a four-week period in the fall in support of the American Diabetes Association Greater New York City Area, the ADA announced Monday.

Duane Reade will conduct the campaign in October and Walgreens will conduct the campaign in November.

March 23, 2012
Shop 'n Save Pharmacy offers DPCA diabetes control program

Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

MINNETONKA, Minn. — Supervalu banner Shop 'n Save Pharmacy has joined the UnitedHealth Group's Diabetes Prevention and Control Alliance.

March 22, 2012
American Diabetes Association: Proposed House budget could harm Stop Diabetes efforts

Changes to the House of Representatives' budget for the upcoming fiscal year could put an American Diabetes Association movement at risk, the ADA said.

ALEXANDRIA, Va. — Changes to the House of Representatives' budget for the upcoming fiscal year could put an American Diabetes Association movement at risk, the ADA said.

March 22, 2012
Diabetics encouraged to get hearing checked

People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

WASHINGTON — People with diabetes are at increased risk of hearing loss, which has prompted two groups to encourage those living with the disease to have their hearing checked.

The American Diabetes Association and the Better Hearing Institute are launching the effort as part of the ADA's Diabetes Alert Day, on Tuesday, which also includes an effort to encourage people to check if they are at risk of developing Type 2 diabetes.

March 22, 2012
Walgreens launches Way to Well Health Tour with AARP

Walgreens will provide prevention and screening services to adults in underserved communities in a program it is sponsoring with AARP, the company said Thursday.

DEERFIELD, Ill. — Walgreens will provide prevention and screening services to adults in underserved communities in a program it is sponsoring with AARP, the company said Thursday.

March 21, 2012
Study examines long-term efficacy of dapagliflozin use in Type 2 diabetes management

An investigational Type 2 diabetes drug may improve glycemic control among patients that are unable to improve their blood sugar with high doses of insulin alone, according to a new study.

NEW YORK — An investigational Type 2 diabetes drug may improve glycemic control among patients that are unable to improve their blood sugar with high doses of insulin alone, according to a new study.

March 20, 2012
Safeway joins USDA on national health-and-wellness communication initiative

Safeway on Tuesday joined forces with the U.S. Department of Agriculture's Center for Nutrition Policy and Promotion on an initiative to develop and promote dietary guidance that links scientific research to the nutrition needs of consumers.

PLEASANTON, Calif. — Safeway on Tuesday joined forces with the U.S. Department of Agriculture's Center for Nutrition Policy and Promotion on an initiative to develop and promote dietary guidance that links scientific research to the nutrition needs of consumers.

March 19, 2012
Crystal Bowersox to give acoustic performance for Walk with Walgreens event

American Idol sensation Crystal Bowersox will deliver an acoustic performance at the second Walk with Walgreens Family Fun Day and Health Fair, to be held March 24, the Diabetes Research Institute Foundation announced Friday.

HOLLYWOOD, Fla. — "American Idol" sensation Crystal Bowersox will deliver an acoustic performance at the second Walk with Walgreens Family Fun Day and Health Fair, to be held March 24, the Diabetes Research Institute Foundation announced Friday.

March 16, 2012
White rice consumption could accelerate diabetes risk

A new study has indicated that the consumption of white rice can increase one's risk of developing Type 2 diabetes.

BOSTON — A new study has indicated that the consumption of white rice can increase one's risk of developing Type 2 diabetes.

March 15, 2012
New research examines cost-effectiveness of lowering HbA1C cutoff

Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

NEW YORK — Reducing the cutoff of hemoglobin A1C to determine if a patient has prediabetes could be cost effective, according to a new study.

March 14, 2012
Staying seated could up diabetes risk for women, study finds

Women that are seated for longer periods of time are more likely to develop diabetes when compared with men, according to a new study.

NEW YORK — Women that are seated for longer periods of time are more likely to develop diabetes when compared with men, according to a new study.

March 14, 2012
Study: H. pylori may be linked to diabetes risk

A bacterium found in the stomach may be associated with diabetes, according to a study published in the Journal of Infectious Diseases.

NEW YORK — A bacterium found in the stomach may be associated with diabetes, according to a study published in the Journal of Infectious Diseases.

March 13, 2012
Pfizer, Biocon end biosimilar insulin deal

Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

NEW YORK — Pfizer and Indian drug maker Biocon have ended a partnership that the companies started in 2010 to develop biosimilar treatments for diabetes, the companies said.

March 9, 2012
APhA, ADA announce new collaboration

A new partnership aims to educate pharmacists, other healthcare professionals, caregivers and patients about diabetes and about how pharmacists can work with physicians to help patients manage the condition.

WASHINGTON — A new partnership aims to educate pharmacists, other healthcare professionals, caregivers and patients about diabetes and about how pharmacists can work with physicians to help patients manage the condition.

The American Pharmacists Association, the APhA Foundation and the American Diabetes Association announced the collaboration Friday, saying it would develop new resources and also promote existing programs, such as the ADA's Stop Diabetes Movement and the APhA's Pharmaceutical Care for Patients with Diabetes certification program.

March 9, 2012
CHPA: Economy, social media changing how America shops 'health'

In excess of $102 billion. That's the value over-the-counter medicine delivers to the U.S. healthcare system, Consumer Healthcare Products Association leaders shared with attendees of the CHPA Annual Executive Conference held here Friday morning.

BONITA SPRINGS, Fla. — In excess of $102 billion. That's the value over-the-counter medicine delivers to the U.S. healthcare system, Consumer Healthcare Products Association leaders shared with attendees of the CHPA Annual Executive Conference held here Friday morning.

March 9, 2012
FDA committee to discuss anti-NGF drug class at meeting

A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

WASHINGTON — A Food and Drug Administration panel will meet Monday to discuss a class of drugs designed to treat chronic painful conditions that currently are under development and the safety issues possibly related to the drugs.

March 8, 2012
Bydureon takes on diabetes

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately.

The market for drugs to treat diabetes — especially Type 2 diabetes — has shown quite a bit of activity lately. At the end of January, the Food and Drug Administration approved Bydureon (exenatide), a once-weekly version of the drug Byetta, which was originally developed by Alkermes and subsequently developed further under an alliance between Amylin Pharmaceuticals and Eli Lilly that the two companies formed in 2002. In November 2011, however, Amylin and Lilly terminated their alliance in the wake of an announced diabetes drug partnership between Lilly and Boehringer Ingelheim.

March 8, 2012
FDA clears Abbott's FreeStyle InsuLinx blood-glucose monitoring system

A blood-glucose monitoring system created by Abbott has received clearance from the Food and Drug Administration.

ALAMEDA, Calif. — A blood-glucose monitoring system created by Abbott has received clearance from the Food and Drug Administration.

March 8, 2012
FDA mulls over making some prescription drugs available over the counter

The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.

SILVER SPRING, Md. — The Food and Drug Administration is looking at the possibility of selling certain prescription drugs over the counter under specific circumstances, the agency said.